How is Tumor Size Reduction Evaluated in Clinical Trials?
In clinical trials, tumor size reduction is often assessed using standardized criteria such as the [RECIST](#) (Response Evaluation Criteria in Solid Tumors). These criteria classify responses into categories like complete response, partial response, stable disease, and progressive disease, based on the changes in tumor size.